A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

Mansoor Raza Mirza, Bente Lund, Jacob Christian Lindegaard, Nina Keldsen, Anders Mellemgaard, René Depont Christensen, Kamma Bertelsen

Research output: Contribution to journalJournal articleResearchpeer-review

11 Citations (Scopus)
Original languageEnglish
JournalGynecologic Oncology
Volume119
Pages (from-to)26-31
Number of pages6
ISSN0090-8258
DOIs
Publication statusPublished - 1 Oct 2010
Externally publishedYes

Bibliographical note

Copyright © 2010 Elsevier Inc. All rights reserved.

Keywords

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols
  • Cystadenocarcinoma, Serous
  • Deoxycytidine
  • Disease-Free Survival
  • Dose-Response Relationship, Drug
  • Doxorubicin
  • Female
  • Humans
  • Middle Aged
  • Ovarian Neoplasms
  • Polyethylene Glycols
  • Survival Rate

Fingerprint Dive into the research topics of 'A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin'. Together they form a unique fingerprint.

Cite this